Tuesday, March 19, 2024

NOW AVAILABLE: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

I am pleased to announce our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, available for purchase and immediate download.
We’re offering special discounted pricing if you order before April 8, 2024.

The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, our 15th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. This 2024 edition includes substantial new material—outlined on page ix of the report overview.

12 chapters, 500+ pages, 262 exhibits, nearly 1,100 endnotes: There is nothing else available that comes close to this valuable resource.

You can pay online with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal. Click here to contact us if you would like to pay by corporate check or ACH.

Email Paula Fein (paula@drugchannels.net) if you’d like to bundle your report purchase with access to DCI’s video webinars.

If you preordered the report, you should have already received an email with download instructions last week. Please contact us if you did not receive your email.

Read on for some additional details.


Twice a year, I research and write two comprehensive, fact-based, and nonpartisan reports on drug channel economics. In some small way, I try to make the world a better and smarter place.

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. So, you can find out what your customers, partners, and competitors are reading.

The chart below illustrates the depth and breadth of the 2024 edition. The numbers indicate the report chapter that corresponds to, explains, and analyzes each channel flow.

  • The 12 chapters are self-contained and do not need to be read in order. (Really!) There are loads of internal hyperlinks to help you navigate the document and customize it to your specific interests and priorities.
  • As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. Many sections and chapters have been expanded and/or reorganized to better cover the latest industry developments. For more details, see the "What’s New in the 2024 Report" section of the report's overview.
  • We are offering the option to download an additional PowerPoint file with images of all 262 exhibits. This popular option helps you share the insights and data with others in your organization. (The exhibits appear within the text for all license versions.)
  • There are a staggering 1,076 (!) endnotes, most of which have hyperlinks to original source materials. These source materials offer a handy way to build your knowledge base beyond what’s included in the full report.
  • As usual, I have reluctantly stripped out the corny jokes and pop culture references. Sadly, there are zero memes and absolutely no references for SpongeBob SquarePants.
If you have any questions (before or after reading the report), please email me.


No comments:

Post a Comment